Literature DB >> 588464

Characterization of a leukotactic factor derived from psoriatic scale.

H Tagami, S Ofuji.   

Abstract

A study was made on the in vitro characteristics and in vivo biological activities of a leukotactic factor derived from psoriatic scale (PLF). Sephadex G-75 chromatography showed that PLF eluted in the region of the 12,500 dalton protein marker. It resisted heating, lyophilization, acidity (pH 3) and alkalinity (pH 11), but was destroyed by trypsin digestion. The substance attracted polymorphonuclear leukocytes (PMNs) in vitro; this ability was inhibited by antiserum to C3a and was partially reduced by antiserum to C5. Although PLF showed strong chemotactic activity for PMNs, its activity for mononuclear cells was only mild. Intradermal injection of PLF into man or guinea-pig produced an erythematous response with dense tissue neutrophilia, the time course of which was similar to that of the Arthus response. PLF also provoked increased vascular permeability in guinea-pig skin. Moreover, repeated intradermal injection of PLF to the same site in guinea-pigs led to moderate acanthosis of the overlying epidermis. These observations strongly suggest that transepidermal migration of leukocytes in psoriatic lesions is provoked by PLF, whose activity appears to reflect that of complement cleavage products, particularly C3a, presumably produced by complement activation in the subcorneal region of the epidermis. Furthermore, it is postulated that PLF may be a factor which plays a crucial role in the production of typical psoriasiform tissue changes.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 588464     DOI: 10.1111/j.1365-2133.1977.tb14128.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  15 in total

1.  Leukocyte chemotactic properties of soluble horny contents in epidermal cysts.

Authors:  H Takematsu; T Terui; W Torinuki; H Tagami
Journal:  Arch Dermatol Res       Date:  1987       Impact factor: 3.017

2.  Alpha 1-proteinase inhibitor in psoriasis: reduced activity in symptom-free patients and during flare.

Authors:  D Barszcz; Z Zarebska; M Glińska-Ferenz; S Jabłońska; M Tigałonowa; W Gliński
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

Review 3.  Immunopathology of psoriasis.

Authors:  S Jablonska; E H Beutner; W L Binder; M Jarzabek-Chorzelska; G Rzesa; O Chowaniec
Journal:  Arch Dermatol Res       Date:  1979-02-23       Impact factor: 3.017

4.  Proinflammatory properties of molluscum bodies.

Authors:  H Takematsu; H Tagami
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

5.  Is chemotactic activity of polymorphonuclear leukocytes increased in psoriasis?

Authors:  A Langner; T P Chorzelski; M Fraczykowska; S Jabłońska
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

6.  Circadian rhythm of the in vivo migration of neutrophils in psoriatic patients.

Authors:  P D Pigatto; A Radaelli; G Tadini; M M Polenghi; L Brambilla; G Altomare; F Carandente
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

7.  Psoriatic leukotactic factor. Further physicochemical characterization and effect on the epidermal cells.

Authors:  H Tagami; Y Kitano; S Suehisa; T Oku; M Yamada
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

8.  Decreased specific anti-elastase activity in the uninvolved skin of patients with psoriasis.

Authors:  W Glinski; M Pierozynska-Dubowska; M Glinska-Ferenz; S Jablońska
Journal:  Arch Dermatol Res       Date:  1991       Impact factor: 3.017

9.  Profile of anti-stratum corneum autoantibodies in psoriatic patients.

Authors:  H Tagami; K Iwatsuki; M Yamada
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

Review 10.  The role of complement-derived mediators in inflammatory skin diseases.

Authors:  H Tagami
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.